Equity Bancshares, Inc.
NYSE:EQBKBanks - Regional
+$0.05 today
- Market cap
- $978.57M
- Beta
- 0.79
- P/E (TTM)
- 35.9
- EPS (TTM)
- $1.29
- Dividend yield
- 1.48%
Volume 0.12M
Average 0.10M
EQBK Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Equity Bancshares, Inc.NYSE: EQBK
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How EQBK compares with its peers on the latest reported figures
- EQBK's LTM Mar 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for EQBK, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding EQBK) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for EQBK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 186.81M | 220.29M | 224.68M | 326.51M | 314.26M |
| Cost of Revenue | 6.22M | 25.29M | 89.05M | 108.85M | 155.89M |
| Gross Profit | 180.59M | 194.99M | 135.63M | 217.67M | 158.37M |
| Gross Margin | 96.7% | 88.5% | 60.4% | 66.7% | 50.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 59.23M | 68.19M | 72M | 80.64M | 68.82M |
| Operating Expenses | 116.15M | 124.71M | 133.21M | 139.39M | 125.84M |
| Depreciation & Amortization | 8.91M | 9.37M | 8.64M | 10.26M | 7.76M |
| EBITDA | 73.34M | 79.65M | 11.05M | 88.54M | 84.83M |
| EBITDA Margin | 39.3% | 36.2% | 4.9% | 27.1% | 27.0% |
| Operating Income | 64.44M | 70.28M | 2.42M | 78.28M | 32.53M |
| Operating Margin | 34.5% | 31.9% | 1.1% | 24.0% | 10.4% |
| Interest Income | 157.37M | 188.25M | 246.71M | 296.84M | 330.84M |
| Interest Expense | 14.79M | 25.42M | 87.69M | 110.68M | 104.75M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (6.15M) |
| Income Before Tax | 64.44M | 70.28M | 2.42M | 78.28M | 26.38M |
| Pre-Tax Margin | 34.5% | 31.9% | 1.1% | 24.0% | 8.4% |
| Income Tax Expense | 11.96M | 12.59M | (5.41M) | 15.66M | 3.65M |
| Net Income | 52.48M | 57.69M | 7.82M | 62.62M | 22.73M |
| Net Margin | 28.1% | 26.2% | 3.5% | 19.2% | 7.2% |
| EPS (Basic) | 3.49 | 3.56 | 0.50 | 4.04 | 1.24 |
| EPS (Diluted) | 3.43 | 3.51 | 0.50 | 4.00 | 1.23 |
| Weighted Avg Shares | 15.02M | 16.21M | 15.54M | 15.64M | 19.04M |
| Weighted Avg Shares (Diluted) | 15.31M | 16.44M | 15.65M | 15.67M | 19.2M |
Equity Bancshares, Inc.
NYSE:EQBK
Intrinsic Alpha fair value
Locked
Current Price
$47.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.